Monograph Details
|
|
Eye Disorders
> Ocular allergy/inflammation
|
|
RESTASIS |
| Manufacturer |
|
Allergan |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Immunomodulator (partial)/ antiinflammatory. |
| Generic Name |
|
Cyclosporine 0.05%; oph emulsion. |
| Indications |
|
To increase tear production caused by ocular inflammation in chronic dry eye disease. |
| Children |
|
<16yrs: not recommended. |
| Adults |
|
≥16yrs: 1 drop every 12 hours. |
| Contraindications |
|
Active ocular infections. |
| Precautions |
|
Herpes keratitis. Contact lenses (remove; may reinsert 15 minutes after instillation). Pregnancy (Cat.C). Nursing mothers. |
| Interactions |
|
Allow at least 15 minutes between dosing of artificial tears. |
| Adverse Reactions |
|
Ocular burning/pain/stinging, conjunctival hyperemia, discharge, foreign body sensation, pruritus, blurring. |
| How Supplied |
|
Single-use vials (0.4mL)—30 |
|
|
|
|
